Anna Scott is a Principal in the Deallus LA office and has successfully delivered a range of projects that have leveraged her diverse consulting experience and strong scientific background. She has also supported clients in the preparation and execution of strategic exercises and scenario workshops.
Anna earned a Ph.D. in Molecular Pharmacology and an M.S. in Regulatory Science from the University of Southern California. Her research on the molecular basis of mental disorders caused by abnormal monoamine neurotransmission was published in the prestigious Journal of Neuroscience and Neuropsychopharmacology. Prior to completing her graduate studies, Anna worked for RCRI, Inc., a consultancy that specialises in regulatory and clinical affairs for the medical device and diagnostics industry.